Can Supplements Protect Your Skin From the Sun? + What to Know About Tanning Peptides

You've got the SPF 50 on, you're chasing the shade, and you're still wondering if there's something you can swallow that helps your skin get through summer...

There is. A handful of compounds have real human data behind them for raising the skin's own UV resistance. But it's important to remember none of them replace sunscreen. Oral photoprotection raises the floor. It doesn't cap the ceiling.

Astaxanthin

Astaxanthin is the red-orange carotenoid that gives salmon and flamingos their color, sourced for supplements from the microalga Haematococcus pluvialis. It's a potent antioxidant, there's a small human trial that's brought a lot of attention to this supplement.

Ito, Seki, and Ueda ran a randomized, double-blind, placebo-controlled study in Nutrients in 2018. Twenty-three healthy Japanese adults took 4 mg of astaxanthin a day for 9 weeks. The astaxanthin group's minimal erythema dose (the UV dose needed to redden skin) rose compared with placebo, and they lost less moisture from UV-exposed skin.

That's an encouraging signal, not a settled one, given the tiny sample, narrow population, and short window. Trials in this space have used doses in the 4 to 12 mg range. What astaxanthin appears to do is nudge the skin's baseline resistance upward, which is a different claim from "protects you from a sunburn."

Astaxanthin sits inside a broader carotenoid family, and Baswan and colleagues' 2021 review in Photodermatology, Photoimmunology & Photomedicine found the same modest pattern across β-carotene, lycopene, and lutein: they lift the skin's resistance to UVB-induced erythema over roughly 10 weeks, at totals around 12 to 24 mg.

Polypodium leucotomos (Fernblock)

Polypodium leucotomos extract, sold as Fernblock and an ingredient inside some sunscreen brands like Heliocare, comes from a South American fern and has one of the the deepest clinical track records of the oral photoprotectants.

UV light damages skin in two steps. First it hits DNA directly. Then it sets off a chain reaction of unstable molecules called free radicals, which keep causing damage after you've left the sun, along with inflammation and the breakdown of collagen. The extract is a strong antioxidant, so it mops up those free radicals. Studies show less DNA damage, less redness, and less collagen breakdown in treated skin after the same UV dose.

That's why it's a helper, not a substitute. It doesn't stop UV from arriving, so it can't replace sunscreen. What it does is give you a second layer of defense for the light that sunscreen misses, and no one applies sunscreen perfectly

Pycnogenol (French maritime pine bark)

Pycnogenol is an extract of bark from French maritime pine trees. Like the fern extract, it's something you swallow rather than apply, and it works by helping skin handle sun and inflammation rather than by blocking light.

The active ingredients are procyanidins, a family of plant compounds that also give red wine and grape seed their antioxidant reputation. Three things they appear to do in skin: soak up the free radicals UV generates, dial down inflammation, and interfere with tyrosinase, the enzyme that pigment-producing cells use to make melanin.

That last one is why the evidence here is strongest for pigmentation rather than sun protection in general. Inflammation is one of the main triggers that tells melanocytes to start producing pigment, so calming inflammation and slowing the pigment machinery both point in the same direction.

The main trial: in 2021, Lima and colleagues gave 44 women with facial melasma either Pycnogenol (75 mg twice a day) or a placebo for two months. Everyone also used a prescription triple-combination cream and SPF 50. The Pycnogenol group's melasma faded faster. It was double-blind and placebo-controlled, which is the design that makes a result trustworthy.

Nicotinamide

Nicotinamide (a form of vitamin B3) plays a different game. It isn't about tempering redness. It enhances repair of UV-induced DNA damage, and the interest has been in preventing skin cancer, not sunburn.

The landmark result was a 23% reduction in new nonmelanoma skin cancers among 386 high-risk immunocompetent adults taking 500 mg twice daily. Then the follow-up complicated it. Allen and colleagues ran the same regimen in 158 organ-transplant recipients in the New England Journal of Medicine in 2023 and found no benefit. A 2026 review in the American Journal of Clinical Dermatology summed it up in its own title: the jury's still out.

So nicotinamide isn't a general-purpose summer supplement. It's a targeted option for people who fit the clinical indications, and it's a conversation to have with a dermatologist rather than a shelf pick.

The "summer glow" shortcuts to skip

Now the part that comes with a warning.

Tanning peptides, almost always melanotan II, are sold online and passed around gyms as injections or nasal sprays that darken skin without sun. The chemistry is real. Your body makes a hormone that tells pigment cells to produce melanin, and melanotan II is a synthetic copy of it that binds the same receptor. It does produce a tan.

The problem is that the receptor it targets isn't only in skin. Versions of it sit throughout the body, so the effects spill well past pigment: nausea, facial flushing, prolonged unwanted erections, and case reports of muscle breakdown and systemic toxicity serious enough to require hospital care.

It's not approved for cosmetic use anywhere, and selling it for human use is illegal in most countries. Because it's unregulated, no one can tell you what's actually in a given vial or how much.

The skin-specific concern is the one dermatologists care most about: it darkens and changes moles. A 2024 review in the Journal of the European Academy of Dermatology and Venereology collected case reports of melanoma appearing in users, including a woman in her forties who developed melanoma on an abdominal mole three months after a single week of use, and a man in his sixties diagnosed with melanoma in situ after four weeks.

Two case reports don't prove the drug caused those cancers. People get melanoma without ever touching a tanning peptide. But there are two reasons not to shrug at it. The first is mechanism: deliberately stimulating pigment cells is a poor idea in anyone with a melanoma risk profile, and no one buying these is being screened. The second is detection: the whole early-warning system for melanoma depends on noticing when a mole changes. A drug that darkens and alters every mole on your body degrades the signal you would use to catch something early.

The more legitimate version:

Melanotan II has a regulated relative. Afamelanotide, sold as Scenesse, works through the same receptor and was FDA-approved in October 2019 as an implant placed under the skin. It treats erythropoietic protoporphyria, a rare inherited condition in which sunlight causes severe burning pain within minutes. For those patients, being able to tolerate daylight is a substantial change in quality of life.

The difference isn't the mechanism. It's that afamelanotide comes with a known dose, a manufactured product, a diagnosis, and a dermatologist watching your skin. Research is expanding: a phase 3 trial is testing it alongside narrowband UVB for vitiligo, and a 2024 review by Polańska and colleagues covers off-label use in polymorphous light eruption and solar urticaria.

Where that leaves the shelf

None of these swap in for sunscreen, clothing, and shade. 

Astaxanthin has modest, real support over weeks, with the wider carotenoid family running alongside it. Fernblock and Pycnogenol earn their spots as adjuncts, strongest for pigment-prone skin. 

Nicotinamide is a targeted tool with a genuinely mixed recent record, not a daily default. And the shortcuts sold for an instant glow are where the risk clearly outruns the reward.